文献
J-GLOBAL ID:201902276942126846
整理番号:19A0023817
HER2-早期乳癌における週1回のNAB-パクリタキセルとドセタキセルの併用によるネオアジュバント療法の無作為化多施設第II相試験【JST・京大機械翻訳】
Randomized Multicenter Phase II Trial of Neoadjuvant Therapy Comparing Weekly Nab-paclitaxel Followed by FEC With Docetaxel Followed by FEC in HER2- Early-stage Breast Cancer
著者 (9件):
Kuwayama Takashi
(Department of Breast Surgical Oncology, Showa University School of Medicine, Tokyo, Japan)
,
Nakamura Seigo
(Department of Breast Surgical Oncology, Showa University School of Medicine, Tokyo, Japan)
,
Hayashi Naoki
(Department of Breast Surgery, St. Luke’s International Hospital, Tokyo, Japan)
,
Takano Toshimi
(Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan)
,
Tsugawa Koichiro
(Department of Breast Surgical Oncology, St. Marianna University School of Medicine, Tokyo, Japan)
,
Sato Takanobu
(Department of Breast Surgical Oncology, Tokyo Medical and Dental University, Tokyo, Japan)
,
Kitani Akira
(Department of Breast Surgery, Tokyo Kyosai Hospital, Tokyo, Japan)
,
Okuyama Hiromi
(Department of Breast Surgical Oncology, Showa University School of Medicine, Tokyo, Japan)
,
Yamauchi Hideko
(Department of Breast Surgery, St. Luke’s International Hospital, Tokyo, Japan)
資料名:
Clinical Breast Cancer
(Clinical Breast Cancer)
巻:
18
号:
6
ページ:
474-480
発行年:
2018年
JST資料番号:
W3206A
ISSN:
1526-8209
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)